市場調查報告書
商品編碼
1516430
心臟監測和心律管理設備的全球市場 2024-2028Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market 2024-2028 |
心臟監測和心律管理設備市場預計在2023-2028年期間將達到74.7672億美元,預測期內複合年成長率為5.38%。
該報告對心臟監測和心律管理設備市場進行了全面分析,包括市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。
它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括全球 CVDS 的日益普及、CM 和 CRM 設備的技術進步以及行動心電遙測(MCT) 的日益普及。
市場範圍 | |
---|---|
基準年 | 2024年 |
結束年份 | 2028年 |
預測期 | 2024-2028 |
成長動力 | 加速度 |
2024年與前一年同期比較 | 4.44% |
複合年成長率 | 5.38% |
增量 | 747,672 萬美元 |
研究指出,供應商不斷增加的策略舉措是推動未來幾年心臟監測和心律管理設備市場成長的關鍵因素。此外,對整合心律不整監測設備開發的日益關注以及心臟植入使用的增加也將帶來巨大的市場需求。
The cardiac monitoring and cardiac rhythm management devices market is forecasted to grow by USD 7476.72 mn during 2023-2028, accelerating at a CAGR of 5.38% during the forecast period. The report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cvds globally, technological advances in cm and crm devices, and increasing uptake of mobile cardiac telemetry (mct).
Technavio's cardiac monitoring and cardiac rhythm management devices market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 4.44% |
CAGR | 5.38% |
Incremental Value | $7476.72mn |
By Product
By End-user
By Geography
This study identifies the increasing strategic initiatives by market vendors as one of the prime reasons driving the cardiac monitoring and cardiac rhythm management devices market growth during the next few years. Also, growing focus on developing integrated arrhythmia-monitoring devices and increasing utilization of cardiac implants will lead to sizable demand in the market.
The report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac monitoring and cardiac rhythm management devices market vendors that include Abbott Laboratories, Adaptive Biotechnologies Corp., Asahi Kasei Corp., BIOTRONIK SE and Co. KG, Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Cell Microsystems Inc., GE Healthcare Technologies Inc., Johnson and Johnson, Koninklijke Philips N.V., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Osypka Medical GmBH, Progetti srl, QIAGEN NV, SCHILLER AG, Stryker Corp., ZOLL Medical Corp., and Shree Pacetronix Ltd.. Also, the cardiac monitoring and cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: